Vitamin D3 Supplementation Modulates Inflammatory Protein CHI3L1/YKL‐40 and Oxidative Stress Status in Multiple Sclerosis

Multiple sclerosis (MS) is characterized by chronic neuroinflammation and oxidative stress. Vitamin D is believed to exert immunomodulatory and antioxidant effects, yet its impact on specific inflammatory proteins such as CHI3L1 (YKL‐40) in MS remains unclear. This study evaluated whether 8‐week vitamin D3 supplementation affects serum CHI3L1 levels, oxidative stress markers, and antioxidant enzyme activities in patients with MS.

• Publication year

  2025

• Venue

  Neuropsychopharmacology Reports

• Publication date

  2025-11-23

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/npr2.70076PMID 41277171PMCID 12641099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic potential of CHI3L1 in osteoarthritis: Inhibition of cartilage matrix degradation and inflammation through TLR4-MAPK-STAT1 pathway.

  2025cited by this paper
• Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections

  2025cited by this paper
• Vitamin D3 Supplementation Modulates Inflammatory Protein CHI3L1/YKL‐40 and Oxidative Stress Status in Multiple Sclerosis

  2025cited by this paper
• Molecular Insight into the Role of Vitamin D in Immune-Mediated Inflammatory Diseases

  2025cited by this paper
• Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells.

  2024cited by this paper
• Recently Updated Role of Chitinase 3-like 1 on Various Cell Types as a Major Influencer of Chronic Inflammation

  2024cited by this paper
• Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer

  2024cited by this paper
• Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment

  2024cited by this paper
• CHI3L1 in Multiple Sclerosis—From Bench to Clinic

  2024cited by this paper
• Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive Review

  2024cited by this paper
• The neuropathobiology of multiple sclerosis

  2024cited by this paper
• Anti-Inflammatory Effect of Vitamin D via Suppression of YKL-40 Production: One of the Possible Mechanisms for Cardiovascular Protection

  2023cited by this paper
• Oxidative Stress and the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Pathway in Multiple Sclerosis: Focus on Certain Exogenous and Endogenous Nrf2 Activators and Therapeutic Plasma Exchange Modulation

  2023cited by this paper
• CHI3L1 signaling impairs hippocampal neurogenesis and cognitive function in autoimmune-mediated neuroinflammation

  2023cited by this paper
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

  2023cited by this paper
• The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update

  2023cited by this paper
• Protein biomarkers in multiple sclerosis

  2023cited by this paper
• Biomarkers in autoimmune diseases of the central nervous system

  2023cited by this paper
• Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis

  2023cited by this paper
• Vitamin D and Vitamin D-Binding Protein in Health and Disease

  2023cited by this paper
• Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model

  2023cited by this paper
• Mechanisms of action of vitamin D in delaying aging and preventing disease by inhibiting oxidative stress.

  2023cited by this paper
• Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?

  2022cited by this paper
• What Is Multiple Sclerosis?

  2022cited by this paper
• Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis.

  2022cited by this paper
• Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway

  2022cited by this paper
• An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

  2022cited by this paper
• Role of Chitinase 3–like 1 as a Biomarker in Multiple Sclerosis

  2022cited by this paper
• Vitamin D status and disability among patients with multiple sclerosis: a systematic review and meta-analysis

  2021cited by this paper
• Vitamin D and Depressive Symptoms in Adults with Multiple Sclerosis: A Scoping Review

  2021cited by this paper
• Burden of multiple sclerosis in Iran from 1990 to 2017

  2021cited by this paper
• Nrf2 Regulates CHI3L1 to Suppress Inflammation and Improve Post-Traumatic Osteoarthritis

  2021cited by this paper
• Synergistic Effects of Exercise Training and Vitamin D Supplementation on Mitochondrial Function of Cardiac Tissue, Antioxidant Capacity, and Tumor Growth in Breast Cancer in Bearing-4T1 Mice

  2021cited by this paper
• Potential Role of CHI3L1+ Astrocytes in Progression in MS

  2021cited by this paper
• Vitamin D Deficiency and the Risk of Cerebrovascular Disease

  2020cited by this paper
• YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation

  2020cited by this paper
• Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)

  2020cited by this paper
• Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats

  2020cited by this paper
• A Brief Review of the Effects of Vitamin D on Multiple Sclerosis

  2020cited by this paper
• Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases

  2020cited by this paper
• Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development

  2020cited by this paper
• NRF2, a Transcription Factor for Stress Response and Beyond

  2020cited by this paper
• Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis

  2020cited by this paper
• The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis

  2020cited by this paper
• Oxidative Stress and Vitamin D as Predictors in Multiple Sclerosis

  2020cited by this paper
• Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome

  2019cited by this paper
• 1, 25-Dihydroxyvitamin D3 activates Apelin/APJ system and inhibits the production of adhesion molecules and inflammatory mediators in LPS-activated RAW264.7 cells

  2019cited by this paper
• An Update on Vitamin D and Disease Activity in Multiple Sclerosis

  2019cited by this paper
• Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.

  2019cited by this paper
• The effect of vitamin D supplementation on oxidative stress parameters: A systematic review and meta‐analysis of clinical trials

  2019cited by this paper
• Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact

  2018cited by this paper
• The controversial role of vitamin D as an antioxidant: results from randomised controlled trials

  2018cited by this paper
• First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid

  2018cited by this paper
• Anti-inflammatory effects of dietary vitamin D3 in patients with multiple sclerosis

  2018cited by this paper
• Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism

  2017cited by this paper
• VITAMIN D BINDING PROTEIN AND 25-HYDROXYVITAMIN D LEVELS: EMERGING CLINICAL APPLICATIONS.

  2017cited by this paper
• Vitamin D and Neurological Diseases: An Endocrine View

  2017cited by this paper
• Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges.

  2017cited by this paper
• Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination

  2016cited by this paper
• The effect of vitamin D administration on serum leptin and adiponectin levels in end-stage renal disease patients on hemodialysis with vitamin D deficiency: A placebo-controlled double-blind clinical trial

  2016cited by this paper
• Studies on oxidants and antioxidants with a brief glance at their relevance to the immune system.

  2016cited by this paper
• Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?

  2016cited by this paper
• Update in vitamin D and multiple sclerosis

  2015cited by this paper
• Serum markers in early-stage and locally advanced melanoma

  2015cited by this paper
• An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis

  2015cited by this paper
• Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

  2015cited by this paper
• Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers.

  2015cited by this paper
• Vitamin D and multiple sclerosis: where do we go from here?

  2014cited by this paper
• Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.

  2014cited by this paper
• Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.

  2012cited by this paper
• Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer

  2011cited by this paper
• 1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of TH17 Cells to Protect against Experimental Autoimmune Encephalomyelitis

  2010cited by this paper
• Immunomodulatory effects of Vitamin D in multiple sclerosis.

  2009cited by this paper
• Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

  2009cited by this paper
• Multiple sclerosis: etiology and treatment strategies.

  2008cited by this paper
• Vitamin D as an immune modulator in multiple sclerosis, a review.

  2008cited by this paper
• Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer

  2007cited by this paper
• Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.

  2006cited by this paper
• Vitamin D intake and incidence of multiple sclerosis

  2004cited by this paper
• High serum YKL-40 level in patients with small cell lung cancer is related to early death.

  2004cited by this paper
• The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.

  2002cited by this paper
• High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

  1994cited by this paper
• A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

  1993cited by this paper

• Vitamin D3 Supplementation Modulates Inflammatory Protein CHI3L1/YKL‐40 and Oxidative Stress Status in Multiple Sclerosis

  2025cites this paper